SCHEMBL20622005

SCHEMBL20622005

O=C(CCc1ccc(O)c(-n2nc3cc4ccccc4cc3n2)c1)NCCO

nearest known ligand 0.56

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 3/20 0.42
TRPV1 Q8NER1 1/20 0.41
ERCC1 P07992 2/20 0.41
ERCC4 Q92889 2/20 0.41
PCNA P12004 1/20 0.41
MAPT P10636 4/20 0.41
KDM4E B2RXH2 3/20 0.41
ALDH1A1 P00352 3/20 0.41
CASP1 P29466 1/20 0.41
CASP7 P55210 1/20 0.41
GAA P10253 3/20 0.40
POLB P06746 1/20 0.40
PKM P14618 1/20 0.40
HTT P42858 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.38
LMNA P02545 1/20 0.38
HPGD P15428 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20598746 0.83 BCHE (0.36) TRPV1ERCC1ERCC4PCNAMAPT
SCHEMBL20599212 0.83 CYP1A2 (0.46) KDM4ELMNA
SCHEMBL20622007 0.82 RPS6KB2 (0.45) KDM4EALDH1A1POLBSMN1; SMN2LMNA
SCHEMBL20598275 0.76 PLA2G4A (0.41) KDM4ELMNA
SCHEMBL5693424 0.75 LMNA (0.51) MAPTKDM4EALDH1A1POLBSMN1; SMN2
SCHEMBL18932566 0.74 LMNA (0.43) TRPV1ERCC1ERCC4MAPTKDM4E
SCHEMBL14348868 0.74 LMNA (0.48) TRPV1ERCC1ERCC4MAPTKDM4E
SCHEMBL18392440 0.74 ERCC1 (0.60) TRPV1ERCC1ERCC4PCNAMAPT
SCHEMBL8160946 0.74 KMT2A (0.55) CNR2PCNAMAPTKDM4EALDH1A1
SCHEMBL4453981 0.74 NPC1 (0.52) KDM4EALDH1A1POLBLMNAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10975040-B2 Hydroxyphenyl naphthotriazoles as polymerizable blockers of high energy light JOHNSON & JOHNSON VISION CARE, INC. (US) 2021-04-13 US disclosed
US-20190002415-A1 HYDROXYPHENYL NAPHTHOTRIAZOLES AS POLYMERIZABLE BLOCKERS OF HIGH ENERGY LIGHT JOHNSON & JOHNSON VISION CARE, INC. 2019-01-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10975040-B2 Hydroxyphenyl naphthotriazoles as polymerizable blockers of high energy light HRH3, HMGB3, CRYAB CNR2 2272/4885TRPV1 2530/4885ERCC1 71/4885
US-20190002415-A1 HYDROXYPHENYL NAPHTHOTRIAZOLES AS POLYMERIZABLE BLOCKERS OF HIGH ENERGY LIGHT HRH3, HMGB3, CRYAB CNR2 2272/4885TRPV1 2530/4885ERCC1 71/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.